
It is hard to stop smoking. But if you are a tobacco user you can quit! More than 46 million Americans have quit smoking for good. Many organizations offer information, counseling, and other services on how to quit, as well as information on where to go for help. Other good resources where help can be found include your doctor, dentist, local hospital, or employer.
More Information From Your American Cancer Society
The following information may also be helpful for you. These materials may be viewed on our Web site or ordered from our toll-free number, 1-800-ACS-2345.
National Organizations and Web Sites*
If you want to quit smoking and need help, contact one of the following organizations. In addition to the American Cancer Society, other sources of patient information and support include:
American Heart Association & American Stroke
Association
Telephone: 1-800-AHA-USA-1 or 1-800-242-8721
Telephone: 1-888-4-STROKE or 1-888-478-7653
Internet address: www.amhrt.org
Internet address: www.strokeassociation.org
American Lung Association
Telephone: 1-800-LUNG-USA (1-800-548-8252)
Internet address: www.lungusa.org
Centers for Disease Control and Prevention
Office on Smoking & Health
Telephone: 1-800-CDC-INFO (1-800-232-4636)
Internet address: www.cdc.gov/tobacco
National Cancer Institute
Cancer Information Service
Telephone: 1-800-4-CANCER (1-800-422-6237)
Internet address: www.cancer.gov
Nicotine Anonymous
Telephone: 1-877-879-6422
Internet address: www.nicotine-anonymous.org
Smokefree.gov
(Online materials, including info on state telephone-based programs)
Telephone: 1-800-QUITNOW (1-800-784-8669)
Internet address: www.smokefree.gov
Smoking Cessation Leadership Center
Telephone: 1-800-QUITNOW or 1-800-784-8669
Internet address: http://smokingcessationleadership.ucsf.edu/
Inclusion on this list does not imply endorsement by the American Cancer Society.
Please call 1-800-ACS-2345 any time, day or night, when you have questions or need help. The American Cancer Society has information, resources, and support available on any cancer-related topic.
Abbot NC, Stead LF, White AR, et al. Hypnotherapy for smoking cessation. Cochrane Database Syst Rev. 2000;(2):CD001008.
American Cancer Society. Cancer Facts & Figures 2007. Atlanta, Ga. 2007.
American Cancer Society. Cancer Prevention & Early Detection Facts & Figures 2005. Available online at: http://www.cancer.org/downloads/STT/CPED2007PWSecuredCPED.pdf. Accessed October 2, 2007.
Agency for Health Care Policy and Research, Clinical Practice Guideline on Smoking Cessation, No. 18, AHCPR, Rockville, MD, April 1997.
American Lung Association. Trends in Tobacco Use, January 2007. Available from http://www.lungusa.org. Accessed October 2, 2007. CDC National Center For Chronic Disease Prevention and Health Promotion. Quit to Live: How and Why to Quit Smoking Today. Available at http://www.cdc.gov/tobacco/news/QuitSmoking.htm. Accessed 9/12/2006. Centers for Disease Control and Prevention (CDC). Annual smoking-attributable mortality, years of potential life lost, and economic costs - United States, 1995-1999. MMWR Morb Mort Wkly Rep. 2002;51 300-303. Available at: http://www.cdc.gov/mmwr//preview/mmwrhtml/mm5114a2.htm. Accessed October 2, 2007. Centers for Disease Control. Best practices for comprehensive tobacco control programs -- August 1999. Atlanta, GA: US Department of Health and Human Services, Public Health Service, CDC, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 1999. Centers for Disease Control. Cigarette Smoking Adults -- United States, 2003. Morbidity and Mortality Weekly Report. Atlanta, GA. Centers for Disease Control and Prevention. Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5420a3.htm. Accessed October 2, 2007. Cogliano V, Straif K, Baan R, Grosse Y, Secretan B, El Ghissassi F. Smokeless tobacco and tobacco-related nitrosamines. Lancet Oncol 2004;5(12):708. Critchley JA, Unal B. Is smokeless tobacco a risk factor for coronary heart disease? A systematic review of epidemiological studies. Eur J Cardiovasc Prev Rehabil. 2004;11(2):101-12. Fagerstron KO, Hughes JR. Nicotine concentrations with concurrent use of cigarettes and nicotine replacement: a review. Nicotine Tob Res. 2002; 4 Suppl 2: 573-9. Fiore MC, Bailey WC, Cohen SJ, et al. Treating Tobacco Use and Dependence. Quick Reference Guide for Clinicians. Rockville, MD: U.S. Department of Health and Human Service. October, 2000. Fiore MC, Smith SS, Jorenby DE, et al. The effectiveness of the nicotine patch for smoking cessation. A meta-analysis. JAMA. 1995; 273: 181. Henley SJ, Connell CJ, Richter P, Husten C, Pechacek T, Calle EE, et al. Tobacco-related disease mortality among men who switched from cigarettes to spit tobacco. Tob Control. 2007;16(1):22-8. Henley SJ, Thun MJ, Connell C, Calle EE. Two large prospective studies of mortality among men who use snuff or chewing tobacco (United States). Cancer Causes Control. 2005;16(4):347-58. Hughes JR. Effects of abstinence from tobacco: valid symptoms and time course. Nicotine Tob Res. 2007 Mar;9(3):315-27. Hurt RD, Sachs DPL, Glover ED, et al. A comparison of sustained-release bupropion and placebo for smoking cessation, New Engl J Med. 1997; 337:1195-1202. Joad JP. Smoking and pediatric respiratory health. Clin Chest Med. 2000 Mar;21:37-46,vii-viii. Joseph Am, Fu SS. Safety issues in pharmacotherapy for smoking in patients with cardiovascular disease. Prog Cardiovasc Dis, 2003; 45: 429-441. Joseph AM, Fu SS. Smoking cessation for patients with cardiovascular disease: what is the best approach? Am J Cardiovasc Drugs.2003; 3: 339-349. Oncken c, Gonzales D, Nides M, Rennard S, Watsky E, Billing, CB, Anziano R, Reeves K. Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation. Arch Intern Med, 2006; 166: 71-77. Mahmud, A, Feely, J. Effect of Smoking on Arterial Stiffness and Pulse Pressure Amplication. Hypertension. 2003; 441: 183. Medioni J, Berlin I, Mallet A. Increased risk of relapse after stopping nicotine replacement therapies: a mathematical modelling approach. Addiction. 2005 Feb;100(2):247-54. Nides, M. Oncken C, Gonzales D, Rennard S, Watsky EJ, Anziano R, Reeves KR. Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo-and bupropion-controlled trial with 1-year follow-up. Arch Intern Med. 2006;166: 1561-1568. Peto R, Darby S, Deo H, et al. Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. BMJ. 2000;321: 323-329. Robertson PB, Walsh MM, Greene JC. Oral effects of smokeless tobacco use by professional baseball players. Adv Dent Res 1997;11(3):307-12. Schroeder SA. What to do with a patient who smokes. Grand Rounds at the University of California, San Francisco. JAMA. 2005; 294: 482-487. Shiffman S, Ferguson SG, Gwaltney CJ, Balabanis MH, Shadel WG. Reduction of abstinence-induced withdrawal and craving using high-dose nicotine replacement therapy. Psychopharmacology.2006;184 ; 637-44. Shiffman S, Scharf DM, Shadel WG, Gwaltney Cj, Dang Q, Paton SM, Clark DB. Analyzing milestones in smoking cessation: illustration in a nicotine patch trial in adult smokers. J Consult Clin Psychol. 2006;74 : 276-85. Shiri R, Häkkinen J, Koskimäki J, et al. Smoking causes erectile dysfunction through vascular disease. Urology. 2006 Dec;68(6):1318-22. Stapleton JA, Russell MA, Feyerabend C, et al. Dose effects and predictors of outcome in a randomized trial of transdermal nicotine patches in general practice. Addiction. 1995; 90:31-42. Tonnesen P, Norregaard J, Simonsen K, et al. A double-blind trial of a 16-hour transdermal nicotine patch in smoking cessation. N Engl J Med. 1991;325::311-315. Tonnesen P. Two and four mg nicotine chewing gum and group counseling in smoking cessation: an open, randomized, controlled trial with a 22 month follow-up. Addictive Behaviors. 1988;13:17-27. Transdermal Nicotine Study Group. Transdermal nicotine for smoking cessation. Six-month results from two multicenter controlled clinical trials. JAMA. 1991;266:3133-3138. Underner M, Paquereau J, Meurice JC. Cigarette smoking and sleep disturbances. Rev Mal Respir, 2006 Jun: 23 Suppl 3: 67-77. US Department of Health & Human Services. The Health Benefits of Smoking Cessation: A Report of the Surgeon General. Centers for Disease Control and Prevention (CDC), Office on Smoking and Health. 1990. Available at: http://profiles.nlm.nih.gov/NN/B/B/C/T/. Accessed October 2, 2007. US Department of Health & Human Services. The Health Consequences of Smoking: A Report of the Surgeon General. Centers for Disease Control and Prevention (CDC), Office on Smoking and Health. 2004. Available at: http://www.cdc.gov/tobacco/data_statistics/sgr/sgr_2004/index.htm. Accessed October 2, 2007. US Department of Health & Human Services. The Health Consequences of Smoking: Nicotine Addiction: A Report of the Surgeon General. Centers for Disease Control and Prevention (CDC), Office on Smoking and Health. 1988. Available at: http://profiles.nlm.nih.gov/NN/B/B/Z/D/. Accessed October 2004. US Department of Health & Human Services. Reducing the Health Consequences of Smoking: 25 years of Progress. A Report of the Surgeon General. Centers for Disease Control and Prevention (CDC), Office on Smoking and Health. 1989. Available at: http://profiles.nlm.nih.gov/NN/B/B/X/S/. Accessed October 2, 2007. US Department of Health and Human Services. Reducing Tobacco Use: A Report of the Surgeon General. Centers for Disease Control and Prevention (CDC), Office on Smoking and Health. 2000. Available at: http://www.cdc.gov/tobacco/data_statistics/sgr/sgr_2000/index.htm Accessed October 2, 2007. U.S. Department of Health and Human Services. The Health Consequences of Involuntary Smoking: A Report of the Surgeon General. Washington, DC: Department of Health and Human Services; 1986. Report No.: Publication No (PHS) 87-8398. White AR, Rampes H, Campbell JL. Acupuncture and related interventions for smoking cessation. Cochrane Database Syst Rev 2006 Jan 25;(1):CD000009. Zevin S, Jacob P 3rd, Benowitz NL. Dose-related cardiovascular and endocrine effects of transdermal nicotine. Clin Pharmacol Ther. 1998; 64: 87-95.
Revised: 10/16/2007